Factors predictive of recurrence after surgery for gastric cancer followed by adjuvant S-1 chemotherapy

Anticancer Research

Volumn 33, Issue 4, 2013, Pages 1747-1752

  Wada, Tomoko ^a   Kunisaki, Chikara ^a   Hasegawa, Shinichi ^a   Takagawa, Ryo ^b   Momiyama, Masashi ^b   Kosaka, Takashi ^b   Makino, Hirochika ^b   Ono, Hidetaka Andrew ^a   Oshima, Takashi ^a   Akiyama, Hirotoshi ^b   Endo, Itaru ^b  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Adjuvant chemotherapy; Gastric cancer; Recurrence; S 1

Indexed keywords

GIMERACIL PLUS OTERACIL POTASSIUM PLUS TEGAFUR;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ANOREXIA; ARTICLE; BLOOD TRANSFUSION; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FATIGUE; FEMALE; HUMAN; LAPAROSCOPIC SURGERY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; MULTIVARIATE ANALYSIS; NEUTROPENIA; PARTIAL GASTRECTOMY; POSTOPERATIVE COMPLICATION; PREDICTIVE VALUE; PRIORITY JOURNAL; RASH; RECURRENCE RISK; RETROSPECTIVE STUDY; STOMACH CANCER; TOTAL STOMACH RESECTION; TREATMENT DURATION; TREATMENT OUTCOME; TUMOR RECURRENCE; TUMOR VOLUME; UNIVARIATE ANALYSIS;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTIMETABOLITES, ANTINEOPLASTIC; CHEMOTHERAPY, ADJUVANT; DRUG COMBINATIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OXONIC ACID; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; STOMACH NEOPLASMS; SURVIVAL RATE; TEGAFUR;

EID: 84876749418     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Center for Cancer Control and Information Services [NCC website]. Trend in age-standardized cancer mortality rate, 1958 through 2009. http://ganjoho.jp/pro/statistics/en/gdb-trend.htm [cited 3 August 2011].
2. Shinichi S, Mitsuru S, Toshiharu Y, Taira K, Masashi F, Atsushi N, Hiroshi F, Toshifusa N, Yasuo O, Hiroshi I, Masayuki H, Yoshitaka Y, Akira K, and Kuniyoshi A, for the ACTS-GC Group: Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoro-pyrimidine. N Engl J Med 357(18): 1810-1820, 2007.
3. Hiroko H, Kazumasa F, Yukinori K, Motohiro H, Shoichi N, Eiji M and Toshimasa T: Effect of S-1 adjuvant chemotherapy on survival following recurrence and efficacy of first-line treatment in recurrent gastric cancer. Chemotherapy 56: 436-443, 2010.
4. Sobin LH, Gospodarowicz MK and Wittekind C: TNM 5 classification of malignant tumors, 7th edition, 2010. National Cancer Institute: Common Terminology Criteria for Adverse Events (CTCAE) v4.0, 2009.
5. Chikara K, Hirochika M, Ryo T, Takashi O, Yasuhiko N, Takashi K, Hidetaka A. Ono, Yuichi O, Hirotoshi A, Yasushi I and Hiroshi SDTumor diameter as a prognostic factor in patients with gastric cancer. Ann Surg Oncol 15(7): 1959-1967, 2008.
6. Norio S, Koichi S, Kazuhiro Y, Masafumi I and Seigo K: Multivariate prognostic study on large gastric cancer. J Surg Oncol 96: 14-18, 2007.
7. Hiroaki S, Tomohiro O, Daiki M, Teruhisa S, Shingo K, Shotaro O, Shigeru T, Shunichi T and Masahide I: Macroscopic tumor size as a simple prognostic indicator in patients with gastric cancer. Am J Surg 192: 296-300, 2006.
8. Toru A, Takaki Y, Takafumi W, Tsutomu H, Takashi O, Haruhiko C and Akira T: Macroscopic tumor size as an independent prognostic factor for stage II/III gastric cancer patients who underwent D2 gastrectomy followed by adjuvant chemotherapy with S-1. Gastric Cancer 14(3): 274-278, 2011.
9. Toru A, Takaki Y, Tsutomu H, Hiroshi K, Yo M, Takashi O, Haruhiko C and Akira T: Risk factors for peritoneal recurrence in Stage II/III gastric cancer patients who received S-1 adjuvant chemotherapy after D2 gastrectomy. Ann Surg Oncol 19(5): 1568-1574, 2012.
10. Wasaburo K, Hiroyuki N, Takuo H, Takagane A, Akiya T, Takagi M, Miyashita K, Nishizaki T, Kobayashi O, Takiyama W, Toh Y, Nagaie T, Takagi S, Yamamura Y, Yanaoka K, Orita H and Takeuchi M: S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): A phase III trial. Lancet Oncol 9: 215-221, 2008.
11. Toru A, Takaki Y, Takafumi W, Tsutomu H, Takashi O, Haruhiko C and Akira T: Survival and prognosticators of gastric cancer that recurs after adjuvant chemotherapy with S-1. Gastric Cancer 14: 150-154, 2011
12. Kitagawa M, Ichikawa D, Okamoto K, Shiozaki A, Fujiwara H, Kuriu Y, Ikoma H, Nakanishi M, Ochiai T, Sakakura C, Kokuba Y, Sonoyama T and Otsuji E: The role of adjuvant chemotherapy with S-1 for gastric cancer patients. Jpn J Cancer Chemother 37(10): 1917-1919, 2010.